Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction

Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy

(2010) S. Chabroux et al.   DIABETES & METABOLISM

Skin Fluorescence Correlates Strongly with Coronary Artery Calcification Severity in Type 1 Diabetes

(2010) Baqiyyah Conway et al.   Diabetes Technology & Therapeutics

Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease

(2008) Hiroki Ueno et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts

(2008) H. L. Nienhuis et al.   RHEUMATOLOGY

Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia

(2007) Christian Ott et al.   ATHEROSCLEROSIS

Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products

(2007) Douwe J. Mulder et al.   ATHEROSCLEROSIS